Adamas Pharmaceuticals, Inc.

Form 483FOIA Uncovered

Emeryville, California, United StatesFEI 3007281742Issued June 28, 2021

View FDA's Record for This Firm

Source: FDA inspection record. Confirmed against FDA's published inspection data for this establishment and inspection date. FDA has published the inspection and what it cited, but not the form itself, which usually takes six to twelve months. To check it, open FDA's record for this establishment on FDA's Data Dashboard, listed under FEI 3007281742.

Observations1

Issue DateJune 28, 2021

StatusNo Warning Letter

Related Inspections2

Establishment Details

Firm: Adamas Pharmaceuticals, Inc.
Location: Emeryville, California, United States
FEI Number: 3007281742
Product Type: Drugs
Issue Date: June 28, 2021
Country: United States

Inspection History, 2017 to 2021

NAI1

VAI1

NAI means No Action Indicated. VAI means Voluntary Action Indicated.

Act on This Form 483

FDA Inspection ReadinessSee how your operations would hold up to the same scrutiny.CAPA & InvestigationsScore how you would investigate and close findings like these.Talk to a SpecialistWalk through these observations with a ComplianceQuest expert.

Adamas Pharmaceuticals, Inc. FDA Form 483, Emeryville, California, June 28, 2021